Clinical Trials

1,096 enrolled 17 charts 1 FDA

Carcinoma, Renal Cell

NCT02477696 2026-05-27

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

533 enrolled 18 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04704934 2026-05-27

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

490 enrolled

Adenocarcinoma, Stomach Neoplasms

NCT04720157 2026-05-27

PSMAddition

1,140 enrolled

Prostatic Neoplasms

NCT04862663 2026-05-27

CAPItello-292

895 enrolled

Breast

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT04928846 2026-05-27

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

698 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04980495 2026-05-27

ADAPT NXT

69 enrolled 10 charts

Myasthenia Gravis

NCT05015608 2026-05-27

SACHI

216 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05052801 2026-05-27

FORTITUDE-101

547 enrolled

Stomach Neoplasms

NCT05100862 2026-05-27

MAHOGANY

780 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT05456191 2026-05-27

ASC4START

MyeloidOther hematologic neoplasm

568 enrolled 11 charts

Leukemia, Myeloproliferative Disorders, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05519085 2026-05-27

SUCCESSOR-1

810 enrolled

Multiple Myeloma, Recurrence

NCT05700448 2026-05-27

Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

150 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT05939414 2026-05-27

PSMA-DC

450 enrolled

Oligometastatic Prostate Cancer (OMPC)

NCT06012435 2026-05-27

A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

762 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT06079671 2026-05-27

eVOLVECervical

800 enrolled

Locally Advanced Cervical Cancer

NCT06120491 2026-05-27

EvoPAR-PR01

1,889 enrolled

Prostatic Neoplasms

NCT06136650 2026-05-27

MK-5684-004

1,314 enrolled

Prostatic Neoplasms

NCT06158841 2026-05-27

CERVINO

380 enrolled

Multiple Myeloma

NCT06346392 2026-05-27

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

592 enrolled

Stomach Neoplasms

NCT06459180 2026-05-27

TroFuse-020

686 enrolled

Uterine Cervical Neoplasms

NCT06492616 2026-05-27

ELEGANT

4,220 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT06517758 2026-05-27

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

146 enrolled

Myasthenia Gravis

NCT06520345 2026-05-27

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

520 enrolled

Prostatic Neoplasms

NCT06619236 2026-05-27

RAINFOL-02

448 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06744920 2026-05-27

RELIEVE

180 enrolled

Myasthenia Gravis

NCT06973187 2026-05-27

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

500 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07099898 2026-05-27

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

420 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07213804 2026-05-27

FRAmework-01

1,080 enrolled

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms

NCT07218926 2026-05-27

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

450 enrolled

GastrointestinalSarcoma

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

NCT07277231 2026-05-27

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

500 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07286266 2026-05-27

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

450 enrolled

Ovarian Neoplasms

NCT07286331 2026-05-27

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

600 enrolled

Endometrial Neoplasms

NCT07407803 2026-05-27

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

177 enrolled

CNS

Neurofibroma, Plexiform

NCT07410117 2026-05-27

ROXI-CAT-I

1,120 enrolled

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07431281 2026-05-27

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

2,130 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT07544654 2026-05-27

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

390 enrolled

Endocrine

Extrapulmonary Neuroendocrine Cancer

NCT07555938 2026-05-27

CEVOLUTION

380 enrolled

Multiple Myeloma

NCT03486873 2026-05-26

MK-3475-587

Other hematologic neoplasm

3,500 enrolled

Hematologic Neoplasms

NCT03520686 2026-05-26

Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer

Phase 3 Terminated

102 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03875235 2026-05-26

TOPAZ-1

810 enrolled 24 charts 1 FDA

Biliary Tract Neoplasms

NCT04624204 2026-05-26

MK 7339-013

672 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT05064059 2026-05-26

MK-4280A-007

441 enrolled 24 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT05184088 2026-05-26

CArdiag

200 enrolled

Immunoglobulin Light-chain Amyloidosis, Amyloid Neuropathies, Familial

NCT05445778 2026-05-26

GLORIOSA

520 enrolled

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT05668988 2026-05-26

A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

324 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05943106 2026-05-26

PATAPSCO

100 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06077760 2026-05-26

INTerpath-002

868 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06136559 2026-05-26

BELLWAVE-011

1,200 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06256588 2026-05-26

JADE